Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy-induced hair loss may be linked to immune system changes, and certain treatments could help but need careful use.

Choose FDA-cleared red light therapy devices and follow guidelines for safe use.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Using existing drugs for new purposes can effectively treat infections resistant to multiple antibiotics.

Microneedles can improve skin disease treatment by delivering drugs directly through the skin.

Activating Nrf2 in skin cells causes skin disease similar to chloracne in mice.

Biomembrane-based hydrogels can effectively promote chronic wound healing.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

Silk fibroin shows promise for wound care but faces challenges in becoming widely available.

Paeonol-loaded gels may help reduce inflammation and skin damage in atopic dermatitis.

A comprehensive system is needed to ensure cosmetics are safe and effective, using global insights and new AI technologies.

Reprogramming adult fibroblasts may enable scar-free healing.

Combination therapy effectively regrows hair and reduces severity in Black children with stubborn Alopecia Areata.

Targeting mitochondria can improve skin health and slow aging.

Red ink tattoos can cause severe skin reactions and complications, especially in those with autoimmune tendencies.

The traditional herbal formulas Yongdamsagan-Tang and Paljung-san, along with the drug finasteride, can reduce inflammation and may work together without affecting each other's effectiveness against benign prostatic hyperplasia.

Mast cell and nerve fiber interactions in mouse skin change with the hair cycle.

Certain mice without specific receptors or mast cells don't lose hair from stress.

Lambs' skin showed similar but more severe responses to a second orf virus infection, involving immune cells and new skin formation.

The study suggests that mast cells might be involved in the hair loss condition telogen effluvium and could be a target for treatment.

Activating the Nrf2 pathway reduces inflammation and cell activation in human hair follicles, suggesting a potential treatment for certain hair loss conditions.

Sorafenib causes skin reactions by increasing the number and activity of skin mast cells.

A gene mutation in mice causes increased mast cells and disorganized hair follicles in their skin.

Adipocytes in atopic dermatitis skin change and worsen inflammation and fibrosis.

Targeting cholesterol, fatty acids, fibrosis, and mast cells may help treat CCCA.

Lichen planopilaris involves disrupted fat metabolism, increased scarring, and mast cell activity.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.